
Journal of Organic Chemistry p. 3275 - 3280 (1994)
Update date:2022-07-29
Topics:
Wenschuh, Holger
Beyermann, Michael
Krause, Eberhard
Brudel, Michael
Winter, Ruediger
et al.
Fmoc amino acid fluorides, recently shown to be a new class of rapid-acting acylating agents in peptide synthesis are well suited for the solid-phase synthesis of medium-sized peptides such as ACP(65-74), magainin-II-amide, and h-CRF.The most important advantage of these reagents is their high reactivity in the coupling of sterically hindered amino acid residues, such as α-aminoisobutyric acid (Aib), results which are at least partly due to the small size of the fluoride leaving group.Both h-(Aib32-35)-CRF(1-41), bearing four consecutive Aib-residues, and alamethicin acid, neither previously accessible by solid-phase synthesis, were successfully synthesized via acid fluorides using unusually short coupling times.In contrast, attempted syntheses via UNCA's and PyBroP activation, both reported to be well suited for sterically hindered systems, failed to give the desired peptides.These remarkable differences prompted a more detailed comparison of the acid fluorides with symmetric anhydrides, UNCA's, and the PyBroP activation technique.Side products formed during the acylation of hindered amino components by Fmoc-Aib-NCA were identified and their formation rationalized.These side products could have their origin in the demonstrated instability of Fmoc-NCA's in the presence of tertiary bases or in a diversion of the position of attack on the NCA from the more hindered to the less-hindered carbonyl function by a bulky nucleophile.Clearly caution is required when such bases are employed to enhance coupling rates for hindered systems.
View MoreJinan YouCheng Pharmatech Co.,Ltd
Contact:+86-18653163205
Address:No.750, Shunhua Road, University Science Park, High-tech Zone, Jinan City
Shanghai Sunwise Chemical Co., Ltd
website:http://www.sunwisechem.com
Contact:86-021-33883180
Address:Room 10E, Building G, Westlink Center, No. 2337 Gudai Road, Minhang District, Shanghai, China PC: 201100
Shanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd
Contact:+86-0372-3662335 +86-0372-3661988
Address:hanling industrial park anyang
Contact:86-791-86629460
Address:1-6F, 118 Xinzhou road, Nanchang, Jiangxi, China
website:http://www.truewingroup.com
Contact:86-311-66699812
Address:NO.600 ZHONGSHAN EAST ROAD SHIJIAZHUANG
Doi:10.1039/c3cy00472d
(2014)Doi:10.1016/j.jfluchem.2012.03.016
(2012)Doi:10.1016/S0040-4020(01)85734-3
(1993)Doi:10.1371/journal.pone.0197835
(2018)Doi:10.1016/S0040-4039(01)00326-4
(2001)Doi:10.1021/jo0622429
(2007)